A comparison of women’s, providers’ and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa
- 11 April 2007
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 114 (5), 569-575
- https://doi.org/10.1111/j.1471-0528.2007.01293.x
Abstract
To compare providers' and women's estimates of duration of pregnancy with ultrasound estimates for determining medical abortion eligibility. Cross-sectional study. Public termination of pregnancy (TOP) services in three provinces. A total of 673 women attending the above services for TOP. Women participating in a medical abortion feasibility study in South Africa provided estimates of pregnancy duration and date of last menstrual period (LMP). Each woman also had clinical and ultrasound exams. We compared estimates using the four methods, calculating the proportion of women in the 'caution zone' (< or = 8 weeks gestation by woman or provider estimate and > 8 weeks by ultrasound). Mean gestational age by each method; difference between provider and LMP estimates and ultrasound estimates; and percentage of women in the 'caution zone'. Women's estimates of pregnancy duration were 19 days fewer than ultrasound estimates (95% CI = -27 to 63). Mean provider- and LMP-based estimates were two (95% CI = -30 to 35) and less than one day(s) (95% CI = -46 to 51) fewer than ultrasound estimates. Comparing provider and ultrasound estimates, 15% of women were in the 'caution zone'; this fell to 12% if estimates of 9 weeks or fewer were considered acceptable. Provider estimates of gestational age were sufficiently accurate for determining eligibility for medical abortion. LMP-based estimates were also accurate on average, but included more extreme differences from ultrasound estimates. Medical abortion could be provided in TOP facilities without ultrasound or with ultrasound on referral.This publication has 24 references indexed in Scilit:
- Medical Abortion: The Possibilities for Introduction in the Public Sector in South AfricaReproductive Health Matters, 2005
- Safety, Efficacy and Acceptability of Mifepristone-Misoprostol Medical Abortion in VietnamInternational Family Planning Perspectives, 1999
- Acceptability and Feasibility of Early Pregnancy Termination by Mifepristone-Misoprostol: Results of a Large Multicenter Trial in the United StatesArchives of Family Medicine, 1998
- Early Pregnancy Termination with Mifepristone and Misoprostol in the United StatesThe New England Journal of Medicine, 1998
- The Acceptability of Medical Abortion in China, Cuba and IndiaInternational Family Planning Perspectives, 1997
- Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.BMJ, 1993
- Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin MisoprostolThe New England Journal of Medicine, 1993
- Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 womenActa Obstetricia et Gynecologica Scandinavica, 1992
- Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin AnalogueThe New England Journal of Medicine, 1990